NewcelX Ltd. cotiza a 2.87 USD y tiene una capitalización bursátil de $17M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
NewcelX Ltd., a biopharmaceutical company, engages in developing transformative stem-cell-derived therapies for Diabetes. The company develops NCEL-101, a cellular therapy product based on enriched pancreatic islet-like clusters for the treatment of Type 1 diabetes and Type 2 insulin dependent diabetes; AstroRx, an off…
| Métrica | NCEL | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -114.5% | -40.4% | -74.1% |
| ROA | -72.5% | -32.0% | -40.5% |
| Current Ratio | 0.76 | 2.84 | -2.08 |
| Debt / Equity | — | 0.28 | — |